Free Trial

Aspira Women's Health Q2 2023 Earnings Report

Aspira Women's Health logo
$0.09 -0.01 (-6.19%)
As of 04/4/2025 04:00 PM Eastern

Aspira Women's Health EPS Results

Actual EPS
-$0.28
Consensus EPS
-$0.47
Beat/Miss
Beat by +$0.19
One Year Ago EPS
N/A

Aspira Women's Health Revenue Results

Actual Revenue
$2.49 million
Expected Revenue
$2.80 million
Beat/Miss
Missed by -$310.00 thousand
YoY Revenue Growth
N/A

Aspira Women's Health Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Remove Ads

Aspira Women's Health Earnings Headlines

Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
See More Aspira Women's Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aspira Women's Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aspira Women's Health and other key companies, straight to your email.

About Aspira Women's Health

Aspira Women's Health (NASDAQ:AWH), Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

View Aspira Women's Health Profile

More Earnings Resources from MarketBeat